Hims & Hers Health, Inc. (New York Stock Exchange:HIMS)
| Market Cap | 6.14B-52.5% |
| Revenue (ttm) | 2.58B+28.0% |
| Net Income | -142.03M-173.4% |
| EPS | -0.63-178.3% |
| Shares Out | 223.08M |
| PE Ratio | n/a |
| Forward PE | 92.32 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,460,187 |
| Open | 29.20 |
| Previous Close | 29.54 |
| Day's Range | 27.52 - 29.62 |
| 52-Week Range | 13.74 - 65.30 |
| Beta | 2.43 |
| Analysts | Hold |
| Price Target | 32.17(+16.81%) |
| Earnings Date | Nov 9, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About HIMS
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$HIMS stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in HIMS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by HIMS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
HIMS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
HIMS Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Single Reporting Segment | $753.21M | 68.74% |
| Customer acquisition costs | $229.50M | 20.95% |
| Legal contingencies | $47.50M | 4.34% |
| Operations and support | $35.40M | 3.23% |
| Technology and development | $15.31M | 1.40% |
| Marketing | $10.52M | 0.96% |
| Change in fair value of liabilities | $4.22M | 0.39% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New HIMS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to HIMS from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in HIMS
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $199.06M |
| IWMiShares Russell 2000 ETF | $167.20M |
| VBVanguard Morningstar Small-Cap ETF | $144.24M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $82.79M |
| VXFVanguard Extended Market ETF | $72.85M |
| IWOiShares Russell 2000 Growth ETF | $59.75M |
Estimated from each fund’s disclosed top holdings × AUM
HIMS Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from HIMS’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score